Great results as expected from RHC, and a decent forward forecast which would not include anything from acquisitions being considered. It was never going to be easy to match 19% growth next year. The PE is still around 30x, so its not cheap. Out of interest I make comment on Sonic (SHL) whose profit is not too far behind RHC, and have a very strong outlook for FY16, and trade at PE of 21.6. Worth considering for lovers of quality health stocks, as are most on this thread
Great results as expected from RHC, and a decent forward...
Add RHC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$46.81 |
Change
0.190(0.41%) |
Mkt cap ! $10.77B | |||
| Open | High | Low | Value | Volume |
| $46.36 | $46.97 | $46.28 | $2.789M | 59.91K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2 | $46.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $46.84 | 133 | 9 |
View Market Depth
| Last trade - 10.47am 25/07/2024 (20 minute delay) ? |
| RHC (ASX) Chart |